TIMOTHY R WRIGHT
CIK 1288245 · Chief Executive Officer · last filed 2024-04-01
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$7.29M
Companies
3
Total Filings
29
Lifetime Open-Market Net
-$904.7K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Protagenic Therapeutics, Inc.\new (PTIXW) Delisted | Director | — | $0.01 | — | $0 | 1 | 2024-04-01 |
| MDXG | Chief Executive Officer | 1,711,324 | $4.26 | $7.29M | -$904.7K | 10 | 2022-06-13 |
| Covidien plc (COV) Delisted | Senior Vice President | 39,903 | — | — | $0 | 16 | 2010-12-03 |
Recent Filings · Page 2 of 3
29 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-06-11 | MDXG | Grant (A) | +681,818 | $3.37M | EDGAR |
| 2012-05-10 | — | Grant (A) | — | $0 | |
| 2011-08-15 | — | Grant (A) | — | $0 | |
| 2010-12-03 | Covidien plc (COV) Delisted | Tax (F) | −1,615 | -$69.3K | EDGAR |
| 2010-11-10 | Covidien plc (COV) Delisted | Grant (A) | +118 | $0 | EDGAR |
| 2010-08-24 | Covidien plc (COV) Delisted | Grant (A) | +115 | $0 | EDGAR |
| 2010-07-06 | Covidien plc (COV) Delisted | Tax (F) | −2,449 | -$97.2K | EDGAR |
| 2010-05-18 | Covidien plc (COV) Delisted | Grant (A) | +127 | $0 | EDGAR |
| 2010-02-25 | Covidien plc (COV) Delisted | Grant (A) | +183 | $0 | EDGAR |
| 2009-12-02 | Covidien plc (COV) Delisted | Mixed | +6,647 | -$46.1K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.